https://www.selleckchem.com/pr....oducts/trastuzumab-d
At follow-up, the intervention group showed significantly greater reductions in FRAIL scores than the control group (P less then 0.033). In addition, 22.4% of the intervention and 13.7% of the control participants had reverted from pre-frail/frail to robust status, with the difference reaching significance when the intervention was compared with the control group (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.0-2.4) after adjustments for age, sex, living arrangement/marital status and hypercholesterolemia. For indiv
Like
Comment
Share
